463-06-005 ISMRM Abstract

The value of foundation model-driven multiomics for predicting platinum resistance in HGSOC patients

Primary: Body - Pelvis

Secondary: Analysis Methods - Foundation Models

463-06-005 · Image Analysis for Cancer · Tuesday, 12 May, 4:55 PM–5:50 PM · Digital Posters Row D

Keywords: Multi-omics MRI Foundation model Ovarian cancer Platinum resistance

Accepted

Qiu Bi ¹, Li Wu¹, Yunzhu Wu², Meining Chen³

¹Department of MRI, The First People’s Hospital of Yunnan Province. The Affiliated Hospital of Kunming University of Science and Technology, kunming, China

²MR Research Collaboration Team, Shanghai, China

³MR Research collaboration, Siemens Healthineers, Chengdu, China

Presenting Author: Qiu Bi

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. [1] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. [2] Folsom SM, Berger J, Soong TR, Rangaswamy B. Comprehensive Review of Serous Tumors of Tubo-Ovarian Origin: Clinical Behavior, Pathological Correlation, Current Molecular Updates, and Imaging Manifestations. Curr Probl Diagn Radiol. 2023;52(5):425-438. [3] Gonzalez-Martin A, Harter P, Leary A, et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(10):833-848. [4] Bi Q, Miao K, Xu N, et al. Habitat Radiomics Based on MRI for Predicting Platinum Resistance in Patients with High-Grade Serous Ovarian Carcinoma: A Multicenter Study. Acad Radiol. 2024;31(6):2367-2380. [5] Ahn B, Moon D, Kim HS, et al. Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer. Nat Commun. 2024;15(1):4253. [6] Yang Z, Zhang Y, Zhuo L, et al. Prediction of prognosis and treatment response in ovarian cancer patients from histopathology images using graph deep learning: a multicenter retrospective study. Eur J Cancer. 2024;199:113532. [7] Liu L, Wan H, Liu L, et al. Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer. Diagnostics (Basel). 2023;13(4). [8] Wang T, Wang H, Wang Y, et al. MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols. J Ovarian Res. 2022;15(1):6. [9] Boehm KM, Khosravi P, Vanguri R, Gao J, Shah SP. Harnessing multimodal data integration to advance precision oncology. Nat Rev Cancer. 2022;22(2):114-126. [10] Feng L, Liu Z, Li C, et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health. 2022;4(1):e8-e17. [11] Ma J, He Y, Li F, Han L, You C, Wang B. Segment anything in medical images. Nat Commun. 2024;15(1):654. [12] Lu MY, Chen B, Williamson D, et al. A visual-language foundation model for computational pathology. Nat Med. 2024;30(3):863-874.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/463-06-005